Healthstream (HSTM) Receivables (2010 - 2026)

Healthstream (HSTM) has reported Receivables for 17 consecutive years, with $36.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 16.96% year-over-year to $36.8 million in Q2 2026; TTM through Jun 2026 was $36.8 million, a 16.96% increase from a year earlier, with the FY2025 full-year figure at $39.0 million, up 10.41% from the prior year.
• Receivables was $36.8 million for Q2 2026 at Healthstream, down from $43.4 million in the prior quarter.
• Over five years, Receivables peaked at $47.3 million in Q1 2023 and troughed at $31.5 million in Q2 2025.
• A 5-year average of $37.8 million and a median of $36.5 million in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables advanced 22.31% in 2022 and fell 18.08% in 2025, its largest moves.
• Over 5 years, Receivables stood at $42.7 million in 2022, then declined by 9.98% to $38.4 million in 2023, then slipped by 8.13% to $35.3 million in 2024, then advanced by 10.41% to $39.0 million in 2025, then declined by 5.63% to $36.8 million in 2026.
• The last three Receivables figures came in at $36.8 million (Q2 2026), $43.4 million (Q1 2026), and $39.0 million (Q4 2025), per Business Quant data.